{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0000", "char_start": 0, "char_end": 2000, "pages": [1], "text": "August 2019\nVolume 35 | Number 9\nNew York State Medicaid Fee-for-Service Program\nPharmacists as Immunizers Fact Sheet\nIn accordance with New York State (NYS) Education Law, NYS Medicaid members can obtain the following\nvaccines when administered to patients 18 years of age and older: Zoster, pneumococcal, meningococcal,\ntetanus, diphtheria, and pertussis vaccines. For patients 2 years of age and older, influenza vaccines may be\nadministered at a Medicaid-enrolled pharmacy. The following conditions apply:\n• Only Medicaid-enrolled pharmacies, in accordance with NYS Education law, will receive reimbursement\nfor immunization services and products. Services must be provided and documented in accordance to\nNYS Education laws and regulations, including the reporting of all immunizations administered to persons\nless than 19 years of age to either the State Department of Health using the New York State Immunization\nInformation System (NYSIIS) or to the New York Citywide Immunization Registry (CIR). Additional\ninformation can be found at: http://www.op.nysed.gov/prof/pharm/pharmimmunizations.htm.\n• Pharmacies will only be able to bill for Medicaid non-dual-eligible enrollees. Dual-eligible enrollees will\ncontinue to access immunization services through Medicare.\n• Medicaid managed care (MMC) members will continue to access immunization services through their\nhealth plans. For Medicaid managed care organization (MCO) billing guidance, please contact the MCO.\n• Reimbursement for these vaccines may be based on a patient-specific order or non-patient-specific\norder. These orders must be kept on file at the pharmacy. The ordering prescriber’s National Provider\nIdentification (NPI) is required on the claim for the claim to be paid.\n• Vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) for individuals\nyounger than 19 years of age are provided to Medicaid members, both fee-for-service (FFS) and MMC,\nfree of charge by the Vaccines for Children (VFC) program", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0001", "char_start": 1750, "char_end": 3750, "pages": [1, 2], "text": "ccines recommended by the Advisory Committee on Immunization Practices (ACIP) for individuals\nyounger than 19 years of age are provided to Medicaid members, both fee-for-service (FFS) and MMC,\nfree of charge by the Vaccines for Children (VFC) program.\nPharmacies wishing to administer VFC-available vaccines to Medicaid members younger than 19\nyears of age may enroll in the VFC program. Note: The VFC program is currently enrolling\npharmacies to receive influenza vaccine only. Pharmacies immunizing patients 18 years of\nage with pneumococcal, meningococcal, tetanus, diphtheria and pertussis vaccines may not bill\nMedicaid for the costs of these vaccines. Patients 18 years of age who are enrolled in Medicaid\nare VFC-eligible and may receive these vaccines through a VFC healthcare practice or clinic.\nNYS Medicaid should never be billed for the cost of any vaccine for persons younger than 19\nyears of age when it is available through the VFC Program. This applies to both FFS and MMC.\nPharmacies that bill Medicaid for the cost of vaccines that are available through the VFC\nProgram are subject to recovery of payment.\nPharmacies that are not enrolled in the VFC program may choose to provide vaccines for\nmembers younger than 19 years of age at no charge to the member or Medicaid program, and\nbe reimbursed an administration fee of $17.85 by NYS Medicaid.\nAdditional information on the VFC Program, based on location, can be found at:\n New York City: https://www1.nyc.gov/site/doh/providers/nyc-med-cir/vaccines-for-\nchildren-requirements.page\n Outside New York City: https://www.health.ny.gov/prevention/immunization/vaccines_\nfor_children/\nContinued on page 3\n\nAndrew M. Cuomo\nGovernor\nState of New York\nHoward A. Zucker, M.D., J.D.\nCommissioner\nNew York State\nDepartment of Health\nDonna Frescatore\nMedicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nNew York State Medicaid Fee-for-", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0002", "char_start": 3500, "char_end": 5500, "pages": [2, 3], "text": "sioner\nNew York State\nDepartment of Health\nDonna Frescatore\nMedicaid Director\nOffice of Health Insurance Programs\nThe Medicaid Update is a monthly publication of the New York State Department of Health.\nIn This Issue…\nNew York State Medicaid Fee-for-Service Program Pharmacists as Immunizers Fact Sheet ....................................... Cover\nPharmacy\nNew York State Medicaid Fee-for-Service Program Pharmacists as Immunizers Fact Sheet (continued) ............................ 3\nNew System Edit to be Implemented to Validate the Ingredient Cost for 340B Drugs ........................................................... 5\nPharmacy Dispensing of Drugs That Require Administration by a Practitioner ..................................................................... 7\nPolicy and Billing\nBilling Changes for OPWDD ICF/IID Providers Effective July 1, 2019 ................................................................................... 8\nAll Providers\nNew York Medicaid EHR Incentive Program .......................................................................................................................... 9\nProvider Training Schedule and Registration ....................................................................................................................... 10\nThe Medicaid Eligibility Verification System (MEVS) and Dispensing Validation System (DVS) Provider Manual .............. 11\nProvider Directory......................................................................................................................................................... 13\nAugust 2019 New York State Medicaid Update pg. 2\n\nPharmacy\nNew York State Medicaid Fee-for-Service Program\nPharmacists as Immunizers Fact Sheet\n(Continued)\nBilling Instructions for FFS\nConsistent with Medicaid immunization policy, pharmacies will bill the administration fee and, when applicable,\nacquisition cost of the vaccine using the appropriate procedure codes. Procedure codes can be found at:\nhttps", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0003", "char_start": 5250, "char_end": 7250, "pages": [3], "text": "Billing Instructions for FFS\nConsistent with Medicaid immunization policy, pharmacies will bill the administration fee and, when applicable,\nacquisition cost of the vaccine using the appropriate procedure codes. Procedure codes can be found at:\nhttps://www.emedny.org/ProviderManuals/Pharmacy/PDFS/Pharmacy_Fee_Schedule.xls.\nPlease note: National Drug Codes (NDCs) are not to be used for billing the vaccine product to Medicaid\nFFS. Reimbursement for the cost of the vaccine for individuals 19 years of age and older will be made at no\nmore than the actual acquisition cost to the pharmacy. No dispensing fee or enrollee co-payment applies.\nPharmacies will bill with a quantity of “1” and a day supply of “1.”\nVaccine Claims Submitted via the NCPDP D.0 Format\nNCPDP D.0. Claim Segment Field Value\n436-E1 (Product/Service ID Qualifier) Value of \"09\" (HCPCS), which qualifies the code submitted\nin field 407-D7 (Product/Service ID) as a procedure code\n407-D7 (Product/Service ID) Enter an applicable procedure code listed in the tables\nbelow. Up to four claim lines can be submitted with one\ntransaction.\nNCPDP D.0 Companion guide can be found at: https://www.emedny.org/HIPAA/5010/transactions/index.aspx\nBilling for Immunizations of Members 19 Years of Age and Older\nFor administration of multiple vaccines on the same date to members 19 years of age and older, procedure code\n“90471” should be used for administration of the first vaccine and “90472” for administration of any other\nvaccines administered on that day. One line should be billed for “90472” indicating the additional number of\nvaccines administered (insert quantity of 1 or 2).\nBilling for Immunizations for Members 19 Years of Age and Younger\nFor VFC-eligible vaccines, whether enrolled in the VFC Program or not, the pharmacy would submit procedure\ncode “90460” (administration of free vaccine) for administration of first or subsequent doses, then submit the\nappropriate vaccine procedure code(s) with a cost of $0.00. A system edi", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0004", "char_start": 7000, "char_end": 9000, "pages": [3, 4], "text": "led in the VFC Program or not, the pharmacy would submit procedure\ncode “90460” (administration of free vaccine) for administration of first or subsequent doses, then submit the\nappropriate vaccine procedure code(s) with a cost of $0.00. A system edit will ensure that when there is an\nincoming claim for the administrative fee (procedure code “90460”) that there is also a claim in history for a VFC-\neligible vaccine procedure code, reimbursed at $0.00. If no history claim is found, then the claim will be denied\nfor the new edit 02291.\nFor National Council for Prescription Drug Programs (NCPDP) claims transactions that are denied for edit 02291,\nthe corresponding Medicaid Eligibility Verification System (MEVS) Denial Reason code “738” will be returned\n“History Not Found for Administrative Vaccine Claim” and NCPDP Reject code “85” “Claim Not Processed.”\nAugust 2019 New York State Medicaid Update pg. 3\n\nThe following procedure codes should be billed for select influenza for those 2 years of age and older;\npneumococcal and meningococcal vaccines for those 18 years of age and older; and zoster for those 50\nyears of age and older:\nProcedure Code Procedure Description\n90620 Meningococcal recombinant protein and outer membrane vesicle vaccine, Serogroup\nB, two-dose schedule, for intramuscular use\n90621 Meningococcal recombinant lipoprotein vaccine, Serogroup B, two- or three- dose\nschedule, for intramuscular use\n90653 Influenza virus vaccine (IIV), preservative free, for use in individuals 65 years of age\nand older, for intramuscular use\n90656 Influenza virus vaccine, split virus, preservative free, for use in individuals 3 years of\nage and older, for intramuscular use\n90658 Influenza virus vaccine, split virus, for use in individuals 3 years of age and older, for\nintramuscular use\n90661 Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic\nfree, for intramuscular use\n90662 Influenza virus vaccine (IIV), split virus, preservative free, enh", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0005", "char_start": 8750, "char_end": 10750, "pages": [4], "text": "duals 3 years of age and older, for\nintramuscular use\n90661 Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic\nfree, for intramuscular use\n90662 Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity\nvia increased antigen content, for intramuscular use\n90670 Pneumococcal conjugate vaccine, 13-valent, for intramuscular use\n90672 Influenza virus vaccine, quadrivalent, live, for intranasal use in individuals 2 years of\nage through 49 years of age\n90673 Influenza virus vaccine, trivalent, derived from recombinant DNA, preservative free, for\nintramuscular use for age 18 years of age and older\n90674 Influenza virus vaccine; quadrivalent, derived from cell cultures, subunit, preservative\nand antibiotic free, for intramuscular use\n90682 Influenza virus vaccine, quadrivalent, (RIV4), derived from recombinant DNA,\npreservative and antibiotic free for intramuscular use\n90686 Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered\nto individuals 3 years of age and older, for intramuscular use\n90688 Influenza virus vaccine, quadrivalent, split virus, when administered to individuals 3\nyears of age and older, with preservative, for intramuscular use\n90714 Tetanus and diphtheria toxoids (Td) adsorbed, preservative free, for use in individuals\nseven years or older, for intramuscular use\n90715 Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), for use in\nindividuals 7 years or older, for intramuscular use\n90732 Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient\ndosage, for use in individuals 2 years of age or older, for subcutaneous or\nintramuscular use\n90733 Meningococcal polysaccharide vaccine (any group(s)), for subcutaneous use, age 2\nyears of age and older\n90734 Meningococcal conjugate vaccine, Serogroups A, C, Y and W-135 (trivalent), for\nintramuscular use, age 11 through 55\n90736 Zoster (shingles) Vaccine, live, for subcutaneo", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0006", "char_start": 10500, "char_end": 12500, "pages": [4, 5], "text": "vaccine (any group(s)), for subcutaneous use, age 2\nyears of age and older\n90734 Meningococcal conjugate vaccine, Serogroups A, C, Y and W-135 (trivalent), for\nintramuscular use, age 11 through 55\n90736 Zoster (shingles) Vaccine, live, for subcutaneous injection, age 50 years and older\n90750 Zoster (shingles) Vaccine, age 50 years and older for intramuscular use\n90756 Influenza virus vaccine, quadrivalent, antibiotic free, for intramuscular use\nAugust 2019 New York State Medicaid Update pg. 4\n\nThe following procedure codes in the table below should be used for the actual administration of the\nvaccines listed above by a pharmacist:\nProcedure Code Procedure Description\n90473 Immunization administration of seasonal influenza intranasal vaccine for ages 19\nyears and older: $8.57\n90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or\nintramuscular injections); one vaccine (single or combination vaccine/toxoid): $13.23\n90472 Immunization administration (includes percutaneous, intradermal, subcutaneous, or\nintramuscular injections); each additional vaccine (single or combination\nvaccine/toxoid) (list separately in addition to code for primary procedure): $13.23\n90460 Immunization administration of free vaccine through VFC Program for ages 19 years\nand younger: $17.85\nContact Information:\n• FFS billing questions should be directed to the eMedNY Call Center at (800) 343–9000.\n• MCO billing questions should be directed to the individual managed care plan. MCO information can be\nfound at: https://mmcdruginformation.nysdoh.suny.edu/.\nAdditional Resources:\n• Additional information on influenza can be found at NYS Department of Health's web site at:\nhttp://www.health.ny.gov/diseases/communicable/influenza/.\n• Center for Disease Control (CDC) vaccine and immunization information can be found at:\nhttp://www.cdc.gov/vaccines/. Providers should check the Pharmacy Provider manual at:\nhttps://www.emedny.org/ProviderManuals/Pharmacy/index.aspx for update", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0007", "char_start": 12250, "char_end": 14250, "pages": [5, 6], "text": "nza/.\n• Center for Disease Control (CDC) vaccine and immunization information can be found at:\nhttp://www.cdc.gov/vaccines/. Providers should check the Pharmacy Provider manual at:\nhttps://www.emedny.org/ProviderManuals/Pharmacy/index.aspx for updates on the procedure codes\nfound in the tables above for vaccines, under “OTC and Supply Fee Schedule.”\n*******************************************************************************************************************\nNew System Edit to be Implemented to Validate the\nIngredient Cost for 340B Drugs\nAs previously communicated in the January 2018 and December 2018 Medicaid Update publications, 340B drug\nclaims submitted to Medicaid via the National Council for Prescription Drug Programs (NCPDP) D.0 format are:\n• required to be properly identified as 340B for both fee-for-service (FFS) and Medicaid managed care\n(MMC) members; as well as\n• submitted at the 340B acquisition cost by invoice to the provider for FFS members, net any manufacturer\ndiscounts and/or other price reductions.\nThe following fields are required on Medicaid 340B drug claims submitted via NCPDP:\nMedicaid Primary Medicaid Secondary Claim\nField\nClaim (Primary: Medicare; Commercial)\n420-DK, Submission Clarification Code (SCC) 20 20\n423-DN, Basis of Cost Determination (BCD)* 08 No Requirements Specific to Medicaid\n409-D9, Ingredient Cost Submitted* 340B Acquisition No Requirements Specific to Medicaid\nCost\n426-DQ, Usual and Customary Cost (U&C) ** Lowest Net Charge Lowest Net Charge to Cash Customers\nto Cash Customers\n*MMC plans should be consulted on their requirements for this field.\n**U&C is defined as the lowest price charged to the general public after all applicable discounts, including promotional discounts and\ndiscounted prices associated with loyalty programs.\nAugust 2019 New York State Medicaid Update pg. 5\n\nPlease Note: All 340B claims are subject to audit and investigation; in addition, claims improperly identified as\n340B and/or claims with unsubst", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0008", "char_start": 14000, "char_end": 16000, "pages": [5, 6], "text": "nd\ndiscounted prices associated with loyalty programs.\nAugust 2019 New York State Medicaid Update pg. 5\n\nPlease Note: All 340B claims are subject to audit and investigation; in addition, claims improperly identified as\n340B and/or claims with unsubstantiated Acquisition Cost may be considered fraudulent claims.\nEffective September 12, 2019, for Medicaid FFS primary claims only, system editing will compare the\ningredient cost submitted (NCPDP field 409-DK) with the 340B ceiling price for the product, as defined by\nHealth Resources and Services Administration (HRSA). The 340B ceiling price refers to the maximum amount\nthat a manufacturer can charge a covered entity for the purchase of a 340B covered outpatient drug.\nThe 340B ceiling price is statutorily defined as the Average Manufacturer Price (AMP) reduced by the rebate\npercentage, which is commonly referred to as the Unit Rebate Amount (URA). HRSA obtains the AMP and URA\ndata from the Centers for Medicare and Medicaid Services (CMS) as part of quarterly reporting for the Medicaid\nDrug Rebate Program. This figure is then multiplied by the package size and case package size to produce a\nprice that is used in the marketplace for purchasing covered outpatient drugs. For example, the AMP minus the\nURA indicates the cost of one pill.\nAny pharmacy that submits a 340B drug claim, whenever the ingredient cost submitted is higher than the ceiling\nprice, will be returned the Medicaid Eligibility Verification System (MEVS) Rx Denial code “708: Exceeds NY\nAllowed Maximum” and the NCPDP Reject code \"23: M/I Ingredient Cost.” The pharmacy would then have\nto resubmit the claim with the correct ingredient cost.\nContact Information:\n• FFS billing questions should be directed to the eMedNY Call Center at (800) 343–9000.\n• Policy questions regarding NYS Medicaid 340B should be directed to: ppno@health.ny.gov.\n• Billing questions regarding MMC plans should be directed to the enrollee’s specific MCO.\nAdditional Resources:\n• Frequently A", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0009", "char_start": 15750, "char_end": 17750, "pages": [6, 7], "text": "Y Call Center at (800) 343–9000.\n• Policy questions regarding NYS Medicaid 340B should be directed to: ppno@health.ny.gov.\n• Billing questions regarding MMC plans should be directed to the enrollee’s specific MCO.\nAdditional Resources:\n• Frequently Asked Questions (FAQ) on HRSA's 340B program, as well as information on how to submit\nadditional questions, can be found on the HRSA website at: https://www.hrsa.gov/opa/faqs/index.html.\n• Information on HRSA requirements when covered entities use 340B drugs for Medicaid members can be\nfound at: https://www.hrsa.gov/opa/programrequirements/medicaidexclusion/index.html.\n• eMedNY Transaction Instructions can be found at: https://www.emedny.org/HIPAA/5010/\ntransactions/index.aspx.\n*******************************************************************************************************************\nAugust 2019 New York State Medicaid Update pg. 6\n\nPharmacy Dispensing of Drugs That Require\nAdministration by a Practitioner\nNew York State (NYS) Medicaid recognizes the need for certain drugs requiring administration by a practitioner\nto be available to members by way of both the Medical Benefit and Pharmacy Benefit. Such practitioner-\nadministered drugs are listed on the Medicaid Pharmacy List of Reimbursable Drugs\n(https://www.emedny.org/info/formfile.aspx) and may be billed directly to the Medicaid Fee-for-Service (FFS)\nprogram by a pharmacy. The intent of this article is to provide guidance for proper dispensing and delivery of\nsuch drugs. Nothing in this policy is meant to suggest that all practitioner-administered drugs must be\ndispensed as a Pharmacy Benefit. The policy regarding practitioner-administered drug billing is addressed in\nthe Physician Manual found at: https://www.emedny.org/ProviderManuals/Physician/index.aspx.\nPractitioner-administered drugs dispensed as a Pharmacy Benefit must be delivered by the pharmacy directly to\nthe site of administration. This is considered “white bagging” and is acceptable under the follo", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0010", "char_start": 17500, "char_end": 19500, "pages": [7], "text": "y.org/ProviderManuals/Physician/index.aspx.\nPractitioner-administered drugs dispensed as a Pharmacy Benefit must be delivered by the pharmacy directly to\nthe site of administration. This is considered “white bagging” and is acceptable under the following guidelines:\n• Drugs should only be dispensed by the pharmacy directly to the patient when they are to be self-\nadministered. The policy surrounding self-administered drug delivery can be found in the July 2019\nMedicaid Update.\n• Prior to delivery of a practitioner-administered drug the dispensing pharmacy must confirm the delivery\naddress, that the member still requires the drug, and that an appointment has been scheduled and\nconfirmed for its administration. Automatic refills are not permitted. The policy surrounding refills can\nbe found in the March 2018 Medicaid Update.\n• Delivery charges may not be billed to the member or NYS Medicaid.\n• The pharmacy is responsible for preparing and delivering the drug in accordance with administration\nguidelines in the package insert, as well as the replacement of improperly stored, lost, or stolen drugs\nuntil confirmed receipt by the authorized agent.\n• The pharmacy is required to obtain documentation of delivery by the receipt of a signature of an\nauthorized agent at the site of administration.\n• All Medicaid claims for drugs that were not deliverable must be reversed within 60 days.\n• Once delivered and signed for, the site of administration is responsible for replacement of improperly\nstored, handled, lost, or stolen practitioner-administered drugs.\nPractitioner-administered drugs dispensed directly to a patient by the pharmacy to bring to their practitioner’s\noffice for administration is considered “brown bagging,” and causes concern regarding proper storage or\nhandling, which can affect the drug efficacy. Brown bagging is not acceptable under NYS Medicaid.\nThis policy refers to any drug being dispensed by a pharmacy for practitioner-administration to a Medicaid FFS\nmember", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0011", "char_start": 19250, "char_end": 21250, "pages": [7, 8], "text": "oncern regarding proper storage or\nhandling, which can affect the drug efficacy. Brown bagging is not acceptable under NYS Medicaid.\nThis policy refers to any drug being dispensed by a pharmacy for practitioner-administration to a Medicaid FFS\nmember, including those billed as a secondary payment. Questions regarding a Medicaid Managed Care Plan\npolicy on practitioner-administered drugs should be directed to the individual plan. Questions and/or clarification\nregarding information contained in this article should be directed to: ppno@health.ny.gov or (518) 486-3209.\n*******************************************************************************************************************\nAugust 2019 New York State Medicaid Update pg. 7\n\nPolicy and Billing\nBilling Changes for OPWDD ICF/IID Providers Effective July 1, 2019\nOn April 4, 2019, the New York State Office for People With Developmental Disabilities (OPWDD) notified\nproviders operating Intermediate Care Facilities for Individuals with Intellectual Disabilities (ICF/IID) of new billing\nrequirements effective July 1, 2019. These new requirements mandate inclusion of the National Provider\nIdentifier (NPI) of the practitioner who completed the annual Level of Care Eligibility Determination (LCED) on\neach claim submission. This requirement was the result of findings by the Centers for Medicare and Medicaid\nServices (CMS) during a Payment Error Rate Measurement (PERM) review of the New York State Medicaid\nprogram. CMS determined that the signed annual LCED for individuals residing in an ICF/IID is the equivalent\nof a physician’s order for service; therefore, each claim must identify the NPI of the physician who\ncompleted/signed the LCED. The basis for this determination is Title 42 Code of Federal Regulations (CFR)\n§456.360.\nPhysician Medicaid Enrollment\nSection 6401(a) of the Affordable Care Act (ACA) establishes requirements regarding provider Medicaid\nenrollment. Specifically, 42 CFR §455.410(b) requires providers reimb", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0012", "char_start": 21000, "char_end": 23000, "pages": [8, 9], "text": "e 42 Code of Federal Regulations (CFR)\n§456.360.\nPhysician Medicaid Enrollment\nSection 6401(a) of the Affordable Care Act (ACA) establishes requirements regarding provider Medicaid\nenrollment. Specifically, 42 CFR §455.410(b) requires providers reimbursed by the fee-for-service (FFS)\nMedicaid program be enrolled in state Medicaid programs if they “order” or “refer” services. Information on the\nMedicaid enrollment process for physicians can be found at:\nhttps://www.emedny.org/info/ProviderEnrollment/index.aspx.\nClaim Submissions\nAs of July 1, 2019, the 837I claim submission for an agency’s ICF/IID billings will be required to incorporate the\nNPI of the physician in the Attending Provider component of the claim form identified in the following segments:\nLoop: 2310A Segment NM109.\nAs referenced in the April 4, 2019 correspondence, effective for dates of service on or after July 1, 2019,\nprovider failure to include this information on claims will result in disallowance.\nWhile claim editing is currently not in place, OPWDD and the New York State Department of Health expect\nsystem edits to be in production in eMedNY on November 21, 2019. OPWDD is in the process of contacting\nspecific providers of ICF/IIDs who are not complying with this requirement regarding corrective action.\nQuestions regarding these requirements should be sent to OPWDD at central.operations@opwdd.ny.gov.\n*******************************************************************************************************************\nAugust 2019 New York State Medicaid Update pg. 8\n\nAll Providers\nNew York Medicaid EHR Incentive Program\nDistribution to Eligible Professionals & Eligible Hospitals Since the Start of the Program in 2011*\nNumber of Payments: Distributed Funds:\n39,332 $974,848,009\n*As of 8/12/2019\nThrough the NY Medicaid Electronic Health Record (EHR) Incentive Program eligible professionals (EPs) and\neligible hospitals (EHs) in New York who adopt, implement, or upgrade certified EHR technology (CEHRT) and\n", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0013", "char_start": 22750, "char_end": 24750, "pages": [9], "text": "39,332 $974,848,009\n*As of 8/12/2019\nThrough the NY Medicaid Electronic Health Record (EHR) Incentive Program eligible professionals (EPs) and\neligible hospitals (EHs) in New York who adopt, implement, or upgrade certified EHR technology (CEHRT) and\nsubsequently become meaningful users of CEHRT, can qualify for financial incentives. The Centers for Medicare\nand Medicaid Services (CMS) is dedicated to improving interoperability and patient access to health information.\nThe NY Medicaid EHR Incentive Program is a part of the CMS Promoting Interoperability Program, but will\ncontinue to operate under the current name, NY Medicaid EHR Incentive Program.\nPayment Year 2018 Meaningful Use Attestation Deadline\nThe Payment Year (PY) 2018 Meaningful Use attestation deadline is September 30, 2019. Providers are\nreminded to log in to NY Medicaid EHR Incentive Program Administrative Support Service (MEIPASS) and\nbegin their attestation. Providers can attest for PY 2018 in MEIPASS at the following link:\nhttps://meipass.emedny.org/ehr/login.xhtml. Providers who have already submitted an attestation for 2018 will\nbe contacted by the NY Medicaid Incentive Program Support Team with status updates. Questions or requests\nfor assistance with the attestation process should be directed to hit@health.ny.gov.\nMeaningful Use Objective 0 – ONC Questions\nEPs are required to attest to Objective 0 – ONC (Office of National Coordinator of Health Information\nTechnology) Questions in which they must demonstrate that they have not restricted compatibility of the\nCEHRT through “information blocking.” Providers should work with their EHR vendor to ensure the technology\nis used correctly and is enabled to meet applicable standards and laws. Providers should also ensure that\norganizational policies and workflows are enabled and do not, in any way, restrict the CEHRT functionality.\nThe Objective 0 – ONC Questions were previously part of the NY Medicaid EHR Incentive Program attestation\npage, however, they ", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0014", "char_start": 24500, "char_end": 26500, "pages": [9, 10], "text": "lso ensure that\norganizational policies and workflows are enabled and do not, in any way, restrict the CEHRT functionality.\nThe Objective 0 – ONC Questions were previously part of the NY Medicaid EHR Incentive Program attestation\npage, however, they are now instituted as Objective 0 in MEIPASS. This new objective includes a series of\nquestions related to information blocking, which is broken down into two measures. There are no right or wrong\nanswers to these questions; the only requirement is that they are answered as accurately and honestly as\npossible. Additional information can be found on the Prevention of Information Attestation Fact Sheet at:\nhttps://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Downloads/EHR_\nInformationBlockingFact-Sheet20171106.pdf.\nWebinars and Q&A Sessions\nA calendar with the date and times of upcoming webinars, as well as registration information, can be found at:\nhttps://www.health.ny.gov/health_care/medicaid/redesign/ehr/calendar/. Upcoming webinars include Security\nRisk Analysis, 2019 Public Health Reporting, EP Meaningful Use – Stage 3, and Patient Engagement for\nEligible Professionals.\nNY Medicaid EHR Incentive Program Tutorial Series\nThe NY Medicaid EHR Incentive Program has produced a series of tutorials to assist providers in preparation of\nthe PY 2018 Meaningful Use Attestation and to aid in the event of a post-payment audit. Registration information\nfor the PY2018 Meaningful Use Attestation Series and the Post-Payment Audit Education Series can be found\nat: https://www.health.ny.gov/health_care/medicaid/redesign/ehr/audit/.\nAugust 2019 New York State Medicaid Update pg. 9\n\nNew York State (NYS) Regional Extension Centers (RECs)\nNYS RECs offer free support to help providers achieve Meaningful Use of CEHRT. Support provided by\nNYS RECs includes, but is not limited to the following: answers to questions regarding the program and\nrequirements, assistance on selecting and using CEHRT, and help meeting program", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0015", "char_start": 26250, "char_end": 28250, "pages": [10], "text": "help providers achieve Meaningful Use of CEHRT. Support provided by\nNYS RECs includes, but is not limited to the following: answers to questions regarding the program and\nrequirements, assistance on selecting and using CEHRT, and help meeting program objectives. NYS RECs offer\nfree assistance for all practices and providers located within New York.\nFor Providers Located:\nInside the 5 boroughs of NYC Outside the 5 boroughs of NYC\nContact: Contact:\nNYC REACH New York eHealth Collaborative (NYeC)\nPhone: 1-347-396-4888 Phone: 1-646-619-6400\nWebsite: https://www.nycreach.org. Website: https://www.nyehealth.org\nEmail: pcip@health.nyc.gov. Email: ep2info@nyehealth.org\nQuestions\nThe EHR Incentive Program has a dedicated support team ready to assist. Please contact the program at:\n1-877-646-5410 (Option 2) or via email at: hit@health.ny.gov.\nPlease Complete the New York Medicaid EHR Incentive Program Customer Satisfaction Survey\nThe NY Medicaid EHR Incentive Program values provider insight. The survey can be found at: https://www.\nsurveymonkey.com/r/NY_EHR.\n*******************************************************************************************************************\nProvider Training Schedule and Registration\nProviders who are new to Medicaid billing, have billing questions, or are interested in learning more about\nePACES, should consider registering for Medicaid training. Various types of training, which includes seminars\nand webinars, are available from eMedNY for providers and their billing staff. Training sessions are available at\nno cost to providers and include information on claim submission, Medicaid Eligibility Verification, and the\neMedNY website.\nSeminars\nSeminars are a valuable opportunity to meet personally with CSRA's eMedNY Regional Representatives.\nSeminars are in-person training sessions with groups of providers and billing staff conducted at locations\nthroughout New York State. A list of upcoming seminars, listed by location, is available on the eMedNY", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0016", "char_start": 28000, "char_end": 30000, "pages": [10, 11], "text": " CSRA's eMedNY Regional Representatives.\nSeminars are in-person training sessions with groups of providers and billing staff conducted at locations\nthroughout New York State. A list of upcoming seminars, listed by location, is available on the eMedNY website\nat: http://www.emedny.org/training/index.aspx.\nWebinars\nWebinar training sessions are conducted online and offer providers the convenience of joining the meeting from\ntheir computer and telephone. Once registration is completed, providers will receive an email with instructions\nto join the online meeting at the appropriate time. No travel is required. Many sessions offer information and\ninstruction about Medicaid's web-based billing and transaction program ePACES.\nThe electronic Provider Assisted Claim Entry System (ePACES) allows enrolled providers to submit the following\ntypes of transactions:\n• Claims\n• Eligibility Verifications\n• Claim Status Requests\n• Prior Approval/DVS Requests\nAugust 2019 New York State Medicaid Update pg. 10\n\nTraining dates, locations, and fast and easy registration are available on the eMedNY website at:\nhttp://www.emedny.org/training/index.aspx. The website is updated quarterly with new sessions. Regional\nRepresentatives from eMedNY look forward to assisting providers at upcoming training sessions. Questions\nrelated to webinar registration should be directed to the eMedNY Call Center at (800) 343–9000.\n*******************************************************************************************************************\nThe Medicaid Eligibility Verification System (MEVS) and Dispensing\nValidation System (DVS) Provider Manual\nThe Medicaid Eligibility Verification System (MEVS) and Dispensing Validation System (DVS) enable providers\nto verify member eligibility prior to provision of services and obtain authorization for specific services covered\nunder DVS. A member, also known as client or recipient, must present an official Common Benefit Identification\nCard (CBIC) to the provider when req", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0017", "char_start": 29750, "char_end": 31750, "pages": [11, 12], "text": "mber eligibility prior to provision of services and obtain authorization for specific services covered\nunder DVS. A member, also known as client or recipient, must present an official Common Benefit Identification\nCard (CBIC) to the provider when requesting services. The issuance of a CBIC does not constitute full\nauthorization for provision of medical services and supplies. The member’s eligibility must be verified through\neMedNY to confirm the member’s eligibility for services and supplies. A provider who does not verify eligibility\nprior to provision of services will risk the possibility of nonpayment for those services.\nThe verification process through eMedNY can be accessed using one of the following methods:\n• Telephone verification process: Audio Response Unit (ARU)\n• Other access methods:\nElectronic Provider Assisted Claim Entry System (ePACES)\nCentral Processing Unit: CPU-to-CPU link\neMedNY eXchange\ndial-up File Transfer Protocol (FTP)\nFile Transfer Service using Simple Object Access Protocol (SOAP)\nCORE Web Services\nAdditional information regarding MEVS access methods is available for review at: https://www.emedny.org/\nProviderManuals/5010/MEVS%20Quick%20Reference%20Guides/5010_MEVS_Methods.pdf.\nMEVS/DVS Provider Manual\nThe MEVS/DVS Provider Manual is a resourceful guide that will introduce providers to:\n• Information about Common Benefit Identification Cards (CBIC)/forms\n• Introduction to the (Telephone Audio Response Unit) Verification\n• Reference tables:\nEligibility Benefit Descriptions\nReject Reason Codes\nDecision Reason Codes\nException Codes\nCounty/District Codes\nNew York City Office Codes\nThe MEVS/DVS Provider Manual is conveniently located on the eMedNY website at: https://www.emedny.org/\nProviderManuals/5010/MEVS/MEVS_DVS_Provider_Manual_(5010).pdf. The MEVS/DVS Provider Manual is\na valuable resource for interpreting the MEVS message providers encounter when checking eligibility.\nAugust 2019 New York State Medicaid Update pg. 11\n\nFor training on Me", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0018", "char_start": 31500, "char_end": 33500, "pages": [11, 12, 13], "text": "/5010/MEVS/MEVS_DVS_Provider_Manual_(5010).pdf. The MEVS/DVS Provider Manual is\na valuable resource for interpreting the MEVS message providers encounter when checking eligibility.\nAugust 2019 New York State Medicaid Update pg. 11\n\nFor training on Medicaid eligibility or any other ePACES related functions, check out the eMedNY training page\nat: https://www.emedny.org/training/index.aspx. Provider questions on messages received should be directed to\nthe eMedNY Call Center at (800) 343-9000.\n*******************************************************************************************************************\nAugust 2019 New York State Medicaid Update pg. 12\n\nProvider Directory\nOffice of the Medicaid Inspector General:\nFor suspected fraud or abuse complaints/allegations, call 1-877-87FRAUD, (877) 873-7283, or visit\nwww.omig.ny.gov.\nProvider Manuals/Companion Guides, Enrollment Information/Forms/Training Schedules:\nPlease visit the eMedNY website at https://www.emedny.org/.\nProviders wishing to listen to the current week’s check/EFT amounts:\nPlease call (866) 307-5549 (available Thursday PM for one week for the current week's amount).\nFor questions about billing and performing MEVS transactions:\nPlease call the eMedNY Call Center at (800) 343-9000.\nProvider Training:\nTo sign up for a provider seminar, please enroll online at https://www.emedny.org/training/index.aspx. For\nindividual training requests, call (800) 343-9000.\nBeneficiary Eligibility:\nCall the Touchtone Telephone Verification System at (800) 997-1111.\nMedicaid Prescriber Education Program:\nFor current information on best practices in pharmacotherapy, please visit the following websites:\nhttp://www.health.ny.gov/health_care/medicaid/program/prescriber_education/presc-educationprog\nhttp://nypep.nysdoh.suny.edu/home\neMedNY\nFor a number of services, including: change of address, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment, please visit: https", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0019", "char_start": 33250, "char_end": 33926, "pages": [13], "text": "-educationprog\nhttp://nypep.nysdoh.suny.edu/home\neMedNY\nFor a number of services, including: change of address, updating an enrollment file due to an ownership\nchange, enrolling another NPI, or revalidating an existing enrollment, please visit: https://www.emedny.org\n/info/ProviderEnrollment/index.aspx and choose the appropriate link based on provider type.\nMedicaid Electronic Health Record (EHR) Incentive Program\nContact the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Georgia Wohnsen, at medicaidupdate@health.ny.gov.\nAugust 2019 New York State Medicaid Update pg. 13", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0020", "char_start": 33676, "char_end": 33926, "pages": [13], "text": "the New York Medicaid EHR Call Center at (877) 646-5410 for assistance.\nComments and Suggestions Regarding This Publication\nPlease contact the editor, Georgia Wohnsen, at medicaidupdate@health.ny.gov.\nAugust 2019 New York State Medicaid Update pg. 13", "chunk_type": "text"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0021::table", "char_start": null, "char_end": null, "pages": [3], "text": ",NCPDP D.0. Claim Segment Field,,,Value,\r\n436-E1 (Product/Service ID Qualifier),,,\"Value of \"\"09\"\" (HCPCS), which qualifies the code submitted\nin field 407-D7 (Product/Service ID) as a procedure code\",,\r\n407-D7 (Product/Service ID),,,\"Enter an applicable procedure code listed in the tables\nbelow. Up to four claim lines can be submitted with one\ntransaction.\",,\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0022::table", "char_start": null, "char_end": null, "pages": [4], "text": ",Procedure Code,,,Procedure Description,\r\n90620,,,\"Meningococcal recombinant protein and outer membrane vesicle vaccine, Serogroup\nB, two-dose schedule, for intramuscular use\",,\r\n90621,,,\"Meningococcal recombinant lipoprotein vaccine, Serogroup B, two- or three- dose\nschedule, for intramuscular use\",,\r\n90653,,,\"Influenza virus vaccine (IIV), preservative free, for use in individuals 65 years of age\nand older, for intramuscular use\",,\r\n90656,,,\"Influenza virus vaccine, split virus, preservative free, for use in individuals 3 years of\nage and older, for intramuscular use\",,\r\n90658,,,\"Influenza virus vaccine, split virus, for use in individuals 3 years of age and older, for\nintramuscular use\",,\r\n90661,,,\"Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic\nfree, for intramuscular use\",,\r\n90662,,,\"Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity\nvia increased antigen content, for intramuscular use\",,\r\n90670,,,\"Pneumococcal conjugate vaccine, 13-valent, for intramuscular use\",,\r\n90672,,,\"Influenza virus vaccine, quadrivalent, live, for intranasal use in individuals 2 years of\nage through 49 years of age\",,\r\n90673,,,\"Influenza virus vaccine, trivalent, derived from recombinant DNA, preservative free, for\nintramuscular use for age 18 years of age and older\",,\r\n90674,,,\"Influenza virus vaccine; quadrivalent, derived from cell cultures, subunit, preservative\nand antibiotic free, for intramuscular use\",,\r\n90682,,,\"Influenza virus vaccine, quadrivalent, (RIV4), derived from recombinant DNA,\npreservative and antibiotic free for intramuscular use\",,\r\n90686,,,\"Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered\nto individuals 3 years of age and older, for intramuscular use\",,\r\n90688,,,\"Influenza virus vaccine, quadrivalent, split virus, when administered to individuals 3\nyears of age and older, with preservative, for intramuscular use\",,\r\n90714,,,\"Tetanus and diphtheria toxoids (Td) adsorbed, preservative free, for use in individuals\nseven years or older, for intramuscular use\",,\r\n90715,,,\"Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), for use in\nindividuals 7 years or older, for intramuscular use\",,\r\n90732,,,\"Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient\ndosage, for use in individuals 2 years of age or older, for subcutaneous or\nintramuscular use\",,\r\n90733,,,\"Meningococcal polysaccharide vaccine (any group(s)), for subcutaneous use, age 2\nyears of age and older\",,\r\n90734,,,\"Meningococcal conjugate vaccine, Serogroups A, C, Y and W-135 (trivalent), for\nintramuscular use, age 11 through 55\",,\r\n90736,,,\"Zoster (shingles) Vaccine, live, for subcutaneous injection, age 50 years and older\",,\r\n90750,,,\"Zoster (shingles) Vaccine, age 50 years and older for intramuscular use\",,\r\n90756,,,\"Influenza virus vaccine, quadrivalent, antibiotic free, for intramuscular use\",,\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0023::table", "char_start": null, "char_end": null, "pages": [5], "text": "Procedure Code,,,,Procedure Description,\r\n90473,,,\"Immunization administration of seasonal influenza intranasal vaccine for ages 19\nyears and older: $8.57\",,\r\n90471,,,\"Immunization administration (includes percutaneous, intradermal, subcutaneous, or\nintramuscular injections); one vaccine (single or combination vaccine/toxoid): $13.23\",,\r\n90472,,,\"Immunization administration (includes percutaneous, intradermal, subcutaneous, or\nintramuscular injections); each additional vaccine (single or combination\nvaccine/toxoid) (list separately in addition to code for primary procedure): $13.23\",,\r\n90460,,,\"Immunization administration of free vaccine through VFC Program for ages 19 years\nand younger: $17.85\",,\r\n,,,,,\r\nContact Information:,,,,,\r\n,• FFS billing questions should be directed to the eMedNY Call Center at (800) 343–9000.,,,,\r\n,• MCO billing questions should be directed to the individual managed care plan. MCO information can be,,,,\r\n,found at: https://mmcdruginformation.nysdoh.suny.edu/.,,,,\r\n,,,,,\r\nAdditional Resources:,,,,,\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0024::table", "char_start": null, "char_end": null, "pages": [5], "text": "• Center for Disease Control (CDC) vaccine and immunization information can be found at:\r\nhttp://www.cdc.gov/vaccines/. Providers should check the Pharmacy Provider manual at:\r\nhttps://www.emedny.org/ProviderManuals/Pharmacy/index.aspx for updates on the procedure codes\r\n\"found in the tables above for vaccines, under “OTC and Supply Fee Schedule.”\"\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0025::table", "char_start": null, "char_end": null, "pages": [5], "text": "\"As previously communicated in the January 2018 and December 2018 Medicaid Update publications, 340B drug\",,,\r\nclaims submitted to Medicaid via the National Council for Prescription Drug Programs (NCPDP) D.0 format are:,,,\r\n,,,\r\n,• required to be properly identified as 340B for both fee-for-service (FFS) and Medicaid managed care,,\r\n,(MMC) members; as well as,,\r\n,\"• submitted at the 340B acquisition cost by invoice to the provider for FFS members, net any manufacturer\",,\r\n,discounts and/or other price reductions.,,\r\n,,,\r\nThe following fields are required on Medicaid 340B drug claims submitted via NCPDP:,,,\r\n,,,\r\n,,Medicaid Primary,Medicaid Secondary Claim\r\nField,,,\r\n,,Claim,(Primary: Medicare; Commercial)\r\n,,,\r\n,,,\r\n,,,\r\n\"420-DK, Submission Clarification Code (SCC)\",,20,20\r\n,,,\r\n,,,\r\n\"423-DN, Basis of Cost Determination (BCD)*\",,08,No Requirements Specific to Medicaid\r\n,,,\r\n,,,\r\n\"409-D9, Ingredient Cost Submitted*\",,340B Acquisition,No Requirements Specific to Medicaid\r\n,,Cost,\r\n,,,\r\n,,,\r\n\"426-DQ, Usual and Customary Cost (U&C) **\",,Lowest Net Charge,Lowest Net Charge to Cash Customers\r\n,,to Cash Customers,\r\n,,,\r\n*MMC plans should be consulted on their requirements for this field.,,,\r\n\"**U&C is defined as the lowest price charged to the general public after all applicable discounts, including promotional discounts and\",,,\r\ndiscounted prices associated with loyalty programs.,,,\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0026::table", "char_start": null, "char_end": null, "pages": [6], "text": ",\r\n\"Please Note: All 340B claims are subject to audit and investigation; in addition, claims improperly identified as\",\r\n340B and/or claims with unsubstantiated Acquisition Cost may be considered fraudulent claims.,\r\n,\r\n\"Effective September 12, 2019, for Medicaid FFS primary claims only, system editing will compare the\",\r\n\"ingredient cost submitted (NCPDP field 409-DK) with the 340B ceiling price for the product, as defined by\",\r\nHealth Resources and Services Administration (HRSA). The 340B ceiling price refers to the maximum amount,\r\nthat a manufacturer can charge a covered entity for the purchase of a 340B covered outpatient drug.,\r\n,\r\nThe 340B ceiling price is statutorily defined as the Average Manufacturer Price (AMP) reduced by the rebate,\r\n\"percentage, which is commonly referred to as the Unit Rebate Amount (URA). HRSA obtains the AMP and URA\",\r\ndata from the Centers for Medicare and Medicaid Services (CMS) as part of quarterly reporting for the Medicaid,\r\nDrug Rebate Program. This figure is then multiplied by the package size and case package size to produce a,\r\n\"price that is used in the marketplace for purchasing covered outpatient drugs. For example, the AMP minus the\",\r\nURA indicates the cost of one pill.,\r\n,\r\n\"Any pharmacy that submits a 340B drug claim, whenever the ingredient cost submitted is higher than the ceiling\",\r\n\"price, will be returned the Medicaid Eligibility Verification System (MEVS) Rx Denial code “708: Exceeds NY\",\r\n\"Allowed Maximum” and the NCPDP Reject code \"\"23: M/I Ingredient Cost.” The pharmacy would then have\",\r\nto resubmit the claim with the correct ingredient cost.,\r\n,\r\nContact Information:,\r\n,• FFS billing questions should be directed to the eMedNY Call Center at (800) 343–9000.\r\n,• Policy questions regarding NYS Medicaid 340B should be directed to: ppno@health.ny.gov.\r\n,• Billing questions regarding MMC plans should be directed to the enrollee’s specific MCO.\r\n,\r\nAdditional Resources:,\r\n,\"• Frequently Asked Questions (FAQ) on HRSA's 340B program, as well as information on how to submit\"\r\n,\"additional questions, can be found on the HRSA website at: https://www.hrsa.gov/opa/faqs/index.html.\"\r\n,• Information on HRSA requirements when covered entities use 340B drugs for Medicaid members can be\r\n,found at: https://www.hrsa.gov/opa/programrequirements/medicaidexclusion/index.html.\r\n,• eMedNY Transaction Instructions can be found at: https://www.emedny.org/HIPAA/5010/\r\n,transactions/index.aspx.\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0027::table", "char_start": null, "char_end": null, "pages": [8], "text": "\"\"\r\n\"\"\r\n\"\"\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0028::table", "char_start": null, "char_end": null, "pages": [9], "text": ",Number of Payments:,,,Distributed Funds:\r\n\"39,332\",,,\"$974,848,009\",\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0029::table", "char_start": null, "char_end": null, "pages": [9], "text": "reminded to log in to NY Medicaid EHR Incentive Program Administrative Support Service (MEIPASS) and\r\nbegin their attestation. Providers can attest for PY 2018 in MEIPASS at the following link:\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0030::table", "char_start": null, "char_end": null, "pages": [9], "text": ",Providers who have already submitted an attestation for 2018 will\r\nbe contacted by the NY Medicaid Incentive Program Support Team with status updates. Questions or requests,\r\nfor assistance with the attestation process should be directed to hit@health.ny.gov.,\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0031::table", "char_start": null, "char_end": null, "pages": [9], "text": "The NY Medicaid EHR Incentive Program has produced a series of tutorials to assist providers in preparation of\r\nthe PY 2018 Meaningful Use Attestation and to aid in the event of a post-payment audit. Registration information\r\nfor the PY2018 Meaningful Use Attestation Series and the Post-Payment Audit Education Series can be found\r\nat:\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0032::table", "char_start": null, "char_end": null, "pages": [10], "text": "For Providers Located:,,,,,\r\n,Inside the 5 boroughs of NYC,,,Outside the 5 boroughs of NYC,\r\n\"Contact:\nNYC REACH\nPhone: 1-347-396-4888\nWebsite: https://www.nycreach.org.\nEmail: pcip@health.nyc.gov.\",,,\"Contact:\nNew York eHealth Collaborative (NYeC)\nPhone: 1-646-619-6400\nWebsite: https://www.nyehealth.org\nEmail: ep2info@nyehealth.org\",,\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0033::table", "char_start": null, "char_end": null, "pages": [10], "text": "Questions\r\nThe EHR Incentive Program has a dedicated support team ready to assist. Please contact the program at:\r\n1-877-646-5410 (Option 2) or via email at: hit@health.ny.gov.\r\n", "chunk_type": "table"}
{"doc_id": "mu_no09_aug19_pr.pdf", "chunk_id": "mu_no09_aug19_pr.pdf::0034::table", "char_start": null, "char_end": null, "pages": [10], "text": ",Please Complete the New York Medicaid EHR Incentive Program Customer Satisfaction Survey,\r\n\"The NY Medicaid EHR Incentive Program values provider insight. The survey can be found at: https://www.\nsurveymonkey.com/r/NY_EHR.\",,\r\n", "chunk_type": "table"}
